immunomodulating therapeutic (Erytech/SQZ biotech)

N/A

Report date: 2025/09/15 10:30:52

Base Information

Drug Nameimmunomodulating therapeutic (Erytech/SQZ biotech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesPhaxiam Therapeutics SASqz Biotechnologies Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A